| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $349,605 ) |
| | 2024 | 2024 | FLUGEN INC | 597 SCIENCE DR | MADISON | WI | 53711-1084 | DANE | USA | SB1AI120269 | IND-enabling studies of an intranasal, single-replication M2SR influenza vaccine | 000 | 5 | NIH | 7/10/2024 | $349,605 |
| | 2024 | 2022 | FLUGEN INC | 597 SCIENCE DR | MADISON | WI | 53711-1084 | DANE | USA | U01AI141310 | Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects | 000 | 3 | NIH | 3/20/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $349,605 ) |
| | 2023 | 2023 | FLUGEN INC | 597 SCIENCE DR | MADISON | WI | 53711-1084 | DANE | USA | SB1AI120269 | IND-enabling studies of an intranasal, single-replication M2SR influenza vaccine | 000 | 4 | NIH | 7/7/2023 | $349,605 |
|
| Issue Date FY: 2022 ( Subtotal = $1,304,188 ) |
| | 2022 | 2022 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | U01AI141310 | Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects | 000 | 3 | NIH | 6/28/2022 | $1,304,188 |
| | 2022 | 2019 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | R44AI109925 | Development of a novel highly effective influenza vaccine | 000 | 4 | NIH | 7/18/2022 | $0 |
| | 2022 | 2018 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | R42AI120269 | Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | 000 | 3 | NIH | 12/7/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,301,311 ) |
| | 2021 | 2021 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | U01AI141310 | Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects | 000 | 2 | NIH | 6/23/2021 | $1,301,311 |
|
| Issue Date FY: 2020 ( Subtotal = $1,311,111 ) |
| | 2020 | 2020 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | U01AI141310 | Safety and Immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects | 000 | 1 | NIH | 8/25/2020 | $1,311,111 |
| | 2020 | 2018 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | R42AI120269 | Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | 001 | 3 | NIH | 6/2/2020 | $0 |
| | 2020 | 2018 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | R42AI120269 | Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | 000 | 3 | NIH | 11/25/2019 | $0 |
| | 2020 | 2018 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | R42AI120269 | Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | 000 | 3 | NIH | 11/25/2019 | $0 |
| | 2020 | 2018 | FLUGEN, INC. | 597 SCIENCE DR STE 10 | MADISON | WI | 53711-1062 | DANE | USA | R42AI120269 | Restimulating memory T cell responses in elderly by a novel, live influenza vaccine | 001 | 3 | NIH | 6/2/2020 | $0 |
|
|
